You just read:

Alcresta Therapeutics' RELiZORB™ Increases Fat Absorption in Adult and Pediatric Patients with Cystic Fibrosis Receiving Enteral Nutrition

News provided by

Alcresta Therapeutics, Inc.

Oct 28, 2016, 14:12 ET